Thomas X. Lu
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Immunology top 5%
- IL-33, ST2, and ILC Pathways
Papers in
-
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 3
- Immunology 11
- IL-33, ST2, and ILC Pathways 10
- Co-authors
- Marc E. RothenbergAriel MunitzMelissa K. MinglerBruce J. AronowEun‐Jin LimPhilip E. PutnamJ. Pablo AboniaMargaret H. Collins
- Journals
- Journal of Allergy and Clinical Immunology (4 papers)The Journal of Immunology (3 papers)Blood (1 paper)Nature Communications (1 paper)Gut (1 paper)
- Partner nations
- United StatesCanadaChina
In The Last Decade
Thomas X. Lu
20 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Cancer Research 1.9k
- Immunology 912
- Rheumatology 487
- Molecular Biology 2.1k
- Immunology and Allergy 131
Countries citing papers authored by Thomas X. Lu
This map shows the geographic impact of Thomas X. Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas X. Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas X. Lu more than expected).
Fields of papers citing papers by Thomas X. Lu
This network shows the impact of papers produced by Thomas X. Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas X. Lu. The network helps show where Thomas X. Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas X. Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 42 | |
| 2 | 2020 | 104 | |
| 3 | 2020 | 20 | |
| 4 | 2020 | 19 | |
| 5 | 2019 | 3 | |
| 6 | MicroRNA Hit paper breakdown → | 2017 | 1824 |
| 7 | 2015 | 74 | |
| 8 | 2014 | 8 | |
| 9 | 2013 | 171 | |
| 10 | 2013 | 45 | |
| 11 | 2013 | 69 | |
| 12 | 2012 | 121 | |
| 13 | 2012 | 58 | |
| 14 | 2011 | 33 | |
| 15 | 2011 | 300 | |
| 16 | 2009 | 480 | |
| 17 | 2009 | 29 | |
| 18 | 2007 | 352 | |
| 19 | Mechanisms of asthma and allergic inflammation Rapid publication IL-13 involvement in eosinophilic esophagitis: Transcriptome analysis and reversibility with glucocorticoids | 2007 | 1 |
| 20 | 2006 | 1 |
About Thomas X. Lu
Thomas X. Lu is a scholar working on Cancer Research, Immunology, Rheumatology, Otorhinolaryngology and Gastroenterology, having authored 20 papers that have together received 3.8k indexed citations. Recurring topics across this work include IL-33, ST2, and ILC Pathways (10 papers), Eosinophilic Esophagitis (6 papers), MicroRNA in disease regulation (6 papers), Eosinophilic Disorders and Syndromes (5 papers), Cancer-related molecular mechanisms research (3 papers), RNA modifications and cancer (2 papers), Microscopic Colitis (2 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Cancer Research (1.9k citations), Immunology (912 citations), Rheumatology (487 citations), Molecular Biology (2.1k citations) and Immunology and Allergy (131 citations). Thomas X. Lu has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Marc E. Rothenberg, Ariel Munitz, Melissa K. Mingler, Bruce J. Aronow, Eun‐Jin Lim, Philip E. Putnam, J. Pablo Abonia, Margaret H. Collins, Yi Wu and María Vicario. Their work appears in journals such as Journal of Allergy and Clinical Immunology, The Journal of Immunology, Blood, Nature Communications and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.